Health Sciences Acquisitions Corporation 2 (NasdaqCM:HSAQ) announced that it has entered into a a purchase agreement for a private placement of 450,000 ordinary shares and 1,500,000 warrants for gross proceeds of $6,000,000 on August 3, 2020. The transaction will include participation from existing investor Hsac 2 Holdings, Llc. The shares have a par value of $0.0001. Each warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of the initial business combination and 12 months from the closing of the transaction and will expire after five years. Each warrant will be non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the sponsor or its permitted transferees. The company will issue securities pursuant to exemption provided under Section 4(a)(2) of the Securities Act. The company has agreed to pay the reasonable fees and expenses with respect to the transaction.